Publications
5539 Results
- Journal / Conference
- Blood 104(11): #949
- Year
- 2004
- Research Committee(s)
- Leukemia
- Study Number(s)
- E2997
Clinical, laboratory, and treatment outcome characteristics of chronic lymphocytic leukemia (CLL) patients with p53 mutations or del(17p) enrolled on a prospective phase III clinical trial: short progression free survival, irrespective of fludarabine-based treatment used
- Journal / Conference
- Blood 104(11):956
- Year
- 2004
- Research Committee(s)
- Leukemia
- Study Number(s)
- E2997
Critical molecular studies to strategically plan therapy in chronic lymphocytic leukemia (CLL): correlating cellular proteins with defined prognostic patient subsets and their response to treatment
- Journal / Conference
- Blood 104(11):#3487
- Year
- 2004
- Research Committee(s)
- Leukemia
- Study Number(s)
- E2997
Outcome of treatment with fludarabine versus fludarabine and cyclophosphamide in chronic lymphocytic leukemia (CLL) is adversely impacted by high risk genetic features: results from ECOG 2997
- Journal / Conference
- American Journal of Pathology 165(1):159-166
- Year
- 2004
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-llike diffuse large B-cell lymphoma
- Journal / Conference
- Journal of Clinical Oncology 22(3):387-389
- Year
- 2004
- Research Committee(s)
- Melanoma
When will melanoma vaccines be proven effective?
- Journal / Conference
- Clinical Cancer Research 10(5):1680-1677
- Year
- 2004
- Research Committee(s)
- Melanoma
A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for malanoma
- Journal / Conference
- International Journal of Radiation Oncology Biology and Physics 59(4):1122-1126
- Year
- 2004
- Research Committee(s)
- Brain
- Study Number(s)
- R9813
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors
- Journal / Conference
- Journal of Clinical Oncology 22(10):1773-1775
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis PMID:15067027
- Journal / Conference
- Proceedings of American Society for Therapeutic Radiology and Oncology, p. S137, abst. #14
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Intergroup 0144: A phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): mature outcome results and pelvic failure analysis
- Journal / Conference
- Cancer 101(5):969-972
- Year
- 2004
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9347 (INT-0142) (E3193)